Notice of Results

RNS Number : 5702D
Yourgene Health PLC
27 June 2019
 

 Yourgene Health plc

("Yourgene Health")

 

Notice of Results

 

Manchester, UK - 27 June 2019: Yourgene Health (AIM: YGEN), the international molecular diagnostics group which commercialises genetic products and services, will announce results for the year ended 31 March 2019 on Wednesday 10 July 2019.

 

 

For more information, please contact:

 

 

Yourgene Health plc

Lyn Rees, Chief Executive Officer

Barry Hextall, Chief Financial Officer

Joanne Cross, Director of Marketing

investors@yourgene-health.com

 

Tel: +44 (0)161 667 1053

 

 

Cairn Financial Advisers LLP (Nomad)

Liam Murray / James Caithie / Ludovico Lazzaretti

 

Tel: +44 (0)20 7213 0880

Stifel Nicolaus Europe Limited (Corporate Broker)

Nicholas Moore / Matthew Blawat / Ben Maddison

 

Tel: +44 (0)20 7710 7600

Vigo Communications (PR)

Ben Simons / Fiona Henson / Antonia Pollock

yourgene@vigocomms.com

Tel: +44 (0)20 7390 0238

 

 

 

About Yourgene Health

Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. 

 

Yourgene develops and commercialises simple and accurate molecular diagnostic solutions, primarily for reproductive health. The Group's products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, male infertility tests and genetic disease tests. Yourgene's commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia.

 

Our product development, research service and commercial capabilities extend across the lifecycle of genetic test development including regulatory submissions. Through our technical expertise and partnerships, Yourgene Health is also extending its genetic testing offering into oncology.

 

Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange's AIM market under the ticker "YGEN". For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORBCGDLIXDBGCL
UK 100

Latest directors dealings